Legato Capital Management LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1442641
San Francisco, CA
Position in KNSA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,409,260
+$804,859 QoQ
Shares Held
70,805
+12.1% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $3,175,895 across 3 Drug Manufacturers - Specialty & Generic names.
All Filings in KNSA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,409,260 | 70,805 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $2,604,401 | 63,137 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $2,238,200 | 57,641 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $1,401,236 | 50,641 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,127,446 | 50,763 | Shares | Other | 2025-05-06 | |
| 2024-12-31 | $1,016,276 | 51,379 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $1,676,953 | 67,105 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $1,249,359 | 66,918 | Shares | Other | 2024-07-26 | |
| No filing history on record for this holder in this stock. | ||||||